Gliclazide Modified Release 30 mg tab

Name: Gliclazide Modified Release 30 mg tab
Brand: CARE FORMULATION LABS PRIVATE LIMITED
Price: 91.0 INR
Availability: InStock

Price 91.0 INR/ Strip

Get a Price/Quote

MOQ : 100 Packs

Gliclazide Modified Release 30 mg tab Specification

Molecular Formula
CHNOS

Ingredients
Gliclazide 30 mg

Feature
Used for the treatment of type 2 diabetes mellitus

Shelf Life
36 Months

Storage Instructions
Store below 25C

Gliclazide Modified Release 30 mg tab Trade Information

Minimum Order Quantity
100 Packs

Supply Ability
5000 Packs Per Month

Delivery Time
7 Days

About Gliclazide Modified Release 30 mg tab

Description

Each Uncoated Modified Release Tablet Containes: Gliclazide IP 30 mg

Doses

As Directed by Physician

Indication

Gliclazide is one of a group of medicines called sulfonylureas that are used to lower the blood sugar level.
Gliclazide tablets are used to treat maturity onset diabetes in patients that is not controlled by diet alone.
They are not for use in children or in patients with diabetes requiring insulin.

Effective Control for Type 2 Diabetes Mellitus

Gliclazide Modified Release 30 mg tablets are specifically designed to help individuals manage type 2 diabetes mellitus efficiently. The modified release formulation ensures a steady release of medication, supporting consistent glucose control throughout the day. Their proven efficacy makes them a reliable choice for healthcare providers and patients alike.

Quality Manufacturing and Wide Distribution

These tablets are produced with stringent quality standards and distributed through a broad network in India, including exporters, wholesalers, and retailers. This ensures wide accessibility for both healthcare institutions and pharmacies, enabling efficient treatment for patients nationwide.

FAQ's of Gliclazide Modified Release 30 mg tab:

Q: How should Gliclazide Modified Release 30 mg tablets be stored to maintain their effectiveness?

A: Gliclazide Modified Release 30 mg tablets should be stored below 25C in a dry place, away from direct sunlight, to preserve their efficacy throughout the 36-month shelf life.

Q: What is the main benefit of using Gliclazide Modified Release 30 mg tablets for diabetes?

A: The key benefit is effective regulation of blood glucose levels in individuals with type 2 diabetes, achieved through the tablet's sustained release profile for prolonged therapeutic action.

Q: When should Gliclazide Modified Release 30 mg tablets be used?

A: These tablets should be taken as prescribed by a healthcare professional, typically once daily with breakfast to ensure optimal blood sugar control throughout the day.

Q: Where are Gliclazide Modified Release 30 mg tablets manufactured and distributed?

A: The tablets are manufactured and widely distributed throughout India, with availability through dealers, distributors, retailers, wholesalers, and other suppliers.

Q: How does the modified release process benefit users of Gliclazide 30 mg tablets?

A: The modified release mechanism allows the active ingredient to be delivered gradually, resulting in more stable blood sugar levels and potentially fewer side effects compared to immediate-release formulations.

Q: What precautions should be taken when using Gliclazide Modified Release tablets?

A: Patients should follow medical instructions, avoid exceeding prescribed doses, and inform their doctor of any other medications or health conditions to avoid potential interactions.

Tell us about your requirement